Elicera Therapeutics AB (publ) (ELIC.ST)
SEK 1.71
(-0.29%)
SEK 1.71
(-0.29%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -14.92 Million | -8.57 Million | -14.29 Million | -905.25 Thousand | -239.15 Thousand | - |
| Net Income | -16.39 Million | -19.36 Million | -13.11 Million | -2.82 Million | -194.25 Thousand | -3525.00 |
| Depreciation & Amortization | 11.76 Thousand | 11.79 Thousand | 11.77 Thousand | 11.77 Thousand | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 1.46 Million | 10.85 Million | -1.18 Million | 1.9 Million | -48.09 Thousand | - |
| Other non-cash items | 10.00 | -73.72 Thousand | -1075.00 | 5419.00 | 3187.00 | 3525.00 |
| Investing Cash Flow | 483.17 Thousand | - | -1000.00 | -8880.00 | 216.81 Thousand | - |
| Investments in PPE | -1000.00 | - | - | -58.88 Thousand | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | -1000.00 | - | - | - |
| Sales/Maturities of investments | 484.17 Thousand | - | - | 50 Thousand | - | - |
| Other Investing Activities | 483.17 Thousand | - | -1000.00 | -8880.00 | 216.81 Thousand | - |
| Financing Cash Flow | - | - | 55.12 Million | 12.44 Million | - | - |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 55.12 Million | 12.44 Million | - | - |
| Other Financing Activities | - | - | 55.12 Million | 12.44 Million | - | - |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 151.08 Thousand | -1.31 Million | 96.06 Thousand | 1.95 Million | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | 1.31 Million | 12.17 Million | -1.28 Million | -45.97 Thousand | -48.09 Thousand | - |
| Cash at beginning of period | 43.82 Million | 52.39 Million | 11.56 Million | 33.82 Thousand | 56.17 Thousand | - |
| Cash at end of period | 29.38 Million | 43.82 Million | 52.39 Million | 11.56 Million | 33.82 Thousand | - |
| Capital Expenditure | -1000.00 | - | - | -58.88 Thousand | - | - |
| Effect of forex changes on cash | - | - | -1.00 | - | - | - |
| Net cash flow / Change in cash | -14.43 Million | -8.57 Million | 40.82 Million | 11.53 Million | -22.34 Thousand | - |
| Free Cash Flow | -14.92 Million | -8.57 Million | -14.29 Million | -964.13 Thousand | -239.15 Thousand | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -5.62 Million | -5.43 Million | -4.74 Million | -16.39 Million | -5.14 Million | -4.46 Million |
| Depreciation & Amortization | 2946.00 | 2946.00 | 2928.00 | 11.76 Thousand | 2946.00 | 2946.00 |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -2.11 Million | -3.89 Million | 8.24 Million | 1.46 Million | -9.2 Million | 2.18 Million |
| Other non-cash items | 1.85 Million | -1.56 Million | 10.00 | 10.00 | 102.86 Thousand | 130.43 Thousand |
| Investing Cash Flow | - | - | -1000.00 | 483.17 Thousand | - | 484.17 Thousand |
| Investments in PPE | - | - | -1000.00 | -1000.00 | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | 484.17 Thousand | - | 484.15 Thousand |
| Other Investing Activities | - | - | -1000.00 | 483.17 Thousand | - | 17.00 |
| Financing Cash Flow | -107.56 Thousand | 20.58 Million | - | - | - | - |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -107.56 Thousand | - | - | - | - | - |
| Common Stock Issuance | -107.56 Thousand | 20.58 Million | - | - | - | - |
| Other Financing Activities | -107.56 Thousand | 20.58 Million | - | - | - | - |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | -1.84 Million | 1.57 Million | -1.78 Million | 151.08 Thousand | 321.82 Thousand | 1.65 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | -266.27 Thousand | -5.47 Million | 10.03 Million | 1.31 Million | -9.52 Million | 529.27 Thousand |
| Cash at beginning of period | 40.7 Million | 29.38 Million | 25.88 Million | 43.82 Million | 40.12 Million | 41.78 Million |
| Cash at end of period | 32.86 Million | 40.7 Million | 29.38 Million | 29.38 Million | 25.88 Million | 40.12 Million |
| Capital Expenditure | - | - | -1000.00 | -1000.00 | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -7.84 Million | 11.32 Million | 3.5 Million | -14.43 Million | -14.24 Million | -1.66 Million |
| Free Cash Flow | -7.73 Million | -9.26 Million | 3.5 Million | -14.92 Million | -14.24 Million | -2.14 Million |
ITVI
MXC
TRIVENI
GMED
UKW
BHP